Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis
CANCER MEDICINE(2022)
Key words
adverse events,atezolizumab plus bevacizumab,elderly patient,hepatocellular carcinoma,survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined